Zepp Health Corporation (ZEPP)
NYSE: ZEPP
· Real-Time Price · USD
49.48
-0.15 (-0.30%)
At close: Oct 03, 2025, 3:59 PM
49.70
0.44%
After-hours: Oct 03, 2025, 05:44 PM EDT
Zepp Health Income Statement
Financials in CNY. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 427.07M | 279.89M | 433.03M | 297.67M | 295.33M | 288.89M | 592.07M | 606.81M | 668.91M | 648.21M | 1.03B | 1.26B | 1.12B | 757.48M | 1.65B | 1.6B | 1.84B | 1.16B |
Cost of Revenue | 272.57M | 175.59M | 273.55M | 176.79M | 176.44M | 182.61M | 386.4M | 401.14M | 521.85M | 544.88M | 818.32M | 1.02B | 921.99M | 605.15M | 1.34B | 1.28B | 1.43B | 900.65M |
Gross Profit | 154.5M | 104.3M | 159.48M | 120.89M | 118.89M | 106.28M | 205.67M | 205.67M | 147.06M | 103.33M | 213.61M | 240.39M | 200.97M | 152.33M | 319.27M | 322.92M | 403.54M | 261.57M |
Operating Income | -43.85M | -133.45M | -65M | -87.89M | -71.69M | -115.03M | 4.47M | 10.93M | -74.67M | -151.62M | -68.32M | -76.34M | -112.06M | -155.52M | 10.02M | 62.32M | 71.69M | -50.85M |
Interest Income | 2.12M | 4.22M | 5.61M | 6.6M | 6.89M | 7.32M | 5.88M | 6.79M | 6.13M | 4.39M | 4.78M | 3.41M | 2.18M | 2.55M | 2.85M | 3.56M | 18.05M | 5.8M |
Pretax Income | -53.9M | -142.58M | -169.65M | -92.95M | -78.48M | -106.49M | 10.78M | 3.28M | -84.33M | -162.41M | -75.34M | -52.96M | -121.79M | -105.67M | 36.49M | 55.15M | 104.04M | -48.79M |
Net Income | -55.64M | -143.37M | -268.55M | -92.89M | -78.75M | -106.78M | -9.12M | 3M | -72.16M | -137.36M | -72.74M | -17.81M | -108.36M | -88.78M | 36.16M | 49.22M | 92.69M | -40.95M |
Selling & General & Admin | 118.15M | 147.86M | 144.04M | 132.65M | 111.97M | 124.28M | 121.86M | 119.52M | 129.61M | 136.52M | 171.83M | 183.99M | 182.33M | 161.36M | 215.87M | 152.22M | 171.35M | 158.11M |
Research & Development | 80.21M | 89.89M | 80.44M | 76.12M | 78.61M | 97.03M | 79.34M | 75.23M | 92.13M | 118.43M | 110.09M | 132.74M | 130.7M | 146.49M | 93.38M | 108.39M | 160.51M | 154.32M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 198.35M | 237.76M | 224.49M | 208.77M | 190.58M | 221.31M | 201.2M | 194.75M | 221.73M | 254.94M | 281.92M | 316.73M | 313.03M | 307.85M | 309.25M | 260.61M | 331.86M | 312.42M |
Interest Expense | 8.95M | 9.86M | 10.52M | 9.04M | 9.98M | 10.43M | 10.26M | 11.77M | 12.71M | 13.38M | 15.51M | 15.73M | 14.31M | 11.68M | 14.34M | 13.46M | 10.36M | 6.73M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 470.93M | 413.34M | 498.03M | 385.56M | 367.02M | 403.92M | 587.61M | 595.89M | 743.58M | 799.83M | 1.1B | 1.33B | 1.24B | 913M | 1.64B | 1.54B | 1.77B | 1.21B |
Income Tax Expense | 1.74M | 798.91K | 98.72M | n/a | 341.53K | 520.56K | 19.79M | 478.71K | -11.98M | -24.85M | -2.41M | -35.02M | -13.19M | -16.76M | 504.81K | 6.21M | 11.62M | -7.7M |
Shares Outstanding (Basic) | 3.96M | 3.86M | 4.04M | 4.04M | 4.05M | 4.06M | 3.77M | 4M | 3.77M | 3.81M | 3.81M | 3.81M | 3.8M | 3.9M | 3.96M | 3.95M | 3.93M | 3.92M |
Shares Outstanding (Diluted) | 3.96M | 4.01M | 4.04M | 4.04M | 4.05M | 4.06M | 3.77M | 4M | 3.81M | 3.83M | 3.83M | 3.83M | 3.84M | 3.9M | 4.13M | 4.16M | 4.12M | 3.92M |
EPS (Basic) | -14 | -37.28 | -66.96 | -23.04 | -19.36 | -26.04 | -2.4 | 0.06 | -18.36 | -35.68 | -19.76 | -4.48 | -27.84 | -22.76 | 9.16 | 12.52 | 23.52 | -10.32 |
EPS (Diluted) | -14 | -35.76 | -66.96 | -23.04 | -19.36 | -3.84 | -0.27 | 0.06 | -18.56 | -35.84 | -19.84 | -4.48 | -28.16 | -23.04 | 8.96 | 12.16 | 22.40 | -10.32 |
EBITDA | -36.2M | -130.11M | -134.28M | -80.65M | -66.05M | -92.02M | 7.61M | 15.42M | -65.43M | -146.08M | -59.15M | -40.78M | -119.08M | -97.5M | 36.16M | 67.62M | 89.53M | -42.52M |
EBIT | -41.31M | -130.11M | -138.4M | -80.65M | -66.05M | -92.02M | 3.57M | 15.42M | -65.43M | -146.08M | -59.15M | -40.78M | -119.08M | -97.5M | 36.16M | 67.62M | 89.53M | -42.52M |
Depreciation & Amortization | 5.11M | n/a | 4.12M | n/a | n/a | n/a | 4.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |